世界の移植保存ソリューション市場 – 業界動向と2030年までの予測

Get Exclusive Sample PDF of this Report Here

移植保存ソリューション市場の分析と規模

移植保存液は、臓器を保存するために使われる溶液です。移植保存液は、臓器が腐敗するのを防ぎ、最終的に移植に使用される前に臓器を保存します。それだけでなく、移植保存液は臓器の温度を維持するためにも使用されます。アルコール消費量の増加による腎不全症例の急増は、世界の移植保存液市場価値の成長を誘発する主な要因の 1 つです。

データブリッジマーケットリサーチは、2022年に2億4,412万米ドルだった世界の移植保存ソリューション市場は、2030年までに3億4,112万米ドルに達し、2023年から2030年の予測期間中に6.0％のCAGRを達成すると予測しています。臓器移植率の上昇により、「静的冷蔵」が世界の移植保存ソリューション市場の技術セグメントを支配しています。データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要企業などの市場シナリオに関する洞察に加えて、詳細な専門家分析、患者疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

移植保存ソリューション市場の範囲とセグメンテーション

Get Exclusive Sample PDF of this Report Here

市場の定義

移植保存液とは、特に移植を待つ間、臓器を保存し、組織の損傷を最小限に抑えるために使用される溶液のことです。臓器は人体から取り出されると外部環境下で崩壊することが多いため、移植前に臓器を保護するために使用されます。

移植保存ソリューションの世界市場の動向

ドライバー

• 臓器移植率の上昇

臓器移植に対する世界的な需要の高まりは、移植保存ソリューション市場を牽引する大きな要因です。移植活動の急増は、いくつかの要因に起因しています。まず、腎不全や肝不全などの慢性疾患や臓器不全の有病率が引き続き上昇しています。さらに、移植手順の進歩により、移植を受ける可能性のある患者のプールが拡大しています。その結果、これらの命を救う手順の成功を最大化するための効果的な保存ソリューションの必要性が高まっています。臓器移植は、多くの末期臓器疾患の好ましい治療法となっています。末期腎疾患、肝硬変、心不全などの症状を持つ患者は、生活の質の向上と生存期間の延長に対する最大の希望として移植に頼っています。その結果、移植保存ソリューションの需要は、世界中で行われる移植手順の増加と密接に関係しています。

• 移植保存ソリューションにおける技術的進歩

Ongoing advancements in preservation techniques and technologies represent a pivotal driver of market growth. These innovations are designed to optimize the preservation of organs and tissues from donors to recipients, ensuring their viability during the critical period between retrieval and transplantation. Preservation solutions have evolved significantly, with improved formulations that better maintain organ integrity and function. These solutions are tailored to specific organs, such as the heart, kidney, liver, and lungs, optimizing their suitability for transplantation. For example, advanced cold storage solutions and perfusion systems enable longer preservation times and better preservation of organ quality.

• Growing Awareness and Education

Increasing awareness about the importance of organ donation and transplantation, coupled with educational initiatives, has resulted in greater public support for transplantation. The general public's understanding of the significance of organ transplantation in saving lives and improving the quality of life has grown significantly. Educational campaigns and advocacy organizations play a crucial role in dispelling myths and misconceptions about organ donation. These efforts highlight the impact of transplantation on recipients and their families, fostering a positive attitude toward organ donation.

Opportunities

• Telemedicine and Remote Monitoring

The adoption of telemedicine and remote monitoring technologies can enhance the quality of transplantation procedures and create opportunities for innovative preservation solutions. Remote monitoring of organ conditions during transportation can be facilitated through technology. Real-time monitoring and assessment of organ function can improve decision-making and reduce the risk of complications during transplantation. The integration of telemedicine into transplantation protocols represents a promising avenue for market growth.

• Emerging and Markets Expansion

Expanding access to transplantation services in emerging markets and regions with previously limited access presents substantial growth opportunities. Collaborations between healthcare organizations, transplant centers, and governmental bodies can facilitate the establishment of transplantation programs. Efforts to improve infrastructure, training, and healthcare systems can create new markets for transplantation preservation solutions. As these regions develop their transplantation capabilities, the demand for preservation solutions is expected to increase.

Restraints/Challenges

• Ethical and Legal Considerations

Ethical considerations surrounding organ transplantation can pose challenges for the global transplantation preservation solutions market. Issues related to informed consent, organ allocation, donor anonymity, and the ethical implications of new transplantation technologies require careful consideration. Ethical dilemmas can affect organ procurement and transplantation processes, leading to delays and controversies. Balancing ethical principles with practical considerations is an ongoing challenge that healthcare professionals, policymakers, and ethicists grapple with. Additionally, legal frameworks surrounding organ transplantation and preservation can vary widely from country to country, adding another layer of complexity. Adhering to these legal requirements while navigating ethical considerations is critical for the successful functioning of the transplantation system.

• Logistics and Transportation

The safe transportation of preserved organs over long distances is a critical but challenging aspect of organ transplantation. Maintaining optimal conditions, including temperature and oxygenation, is essential for preserving organ viability. Logistics and transportation challenges can arise due to factors such as the remoteness of donor and recipient locations, adverse weather conditions, and the need for rapid transportation. Minimizing transit times while ensuring organ safety and quality remains a logistical puzzle.

This global transplantation preservation solutions market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global transplantation preservation solutions market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In January 2023, Transplant surgeons at MedStar Georgetown University Hospital in the Washington Metropolitan area of the United States successfully utilized a new FDA-approved technology, the OrganOx metra, which simulates connecting a liver to its recipient, allowing the donated liver to be preserved for up to 12 hours before being transplanted into the recipient

Global Transplantation Preservation Solutions Market Scope

The global transplantation preservation solutions market is segmented on the basis of technique, preservation solutions and organ type. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technique

• Static Cold Storage
• Hypothermic Perfusion Preservation
• Other

Preservation Solutions

• Viaspan
• Custodiol HTK (Histidine-Tryptophan-Ketoglutarate)
• Renograf
• Hypothermosol
• Perfadex
• Lifor
• Human bioSystem (HBS) Solution
• siRNA Transplant Solutions
• Others

Organ Type

• Kidneys
• Lung
• Liver
• Heart
• Others

Global Transplantation Preservation Solutions Market Regional Analysis/Insights

The global transplantation preservation solutions market is analysed and market size insights and trends are provided by country, technique, preservation solutions and organ type as referenced above.

The countries covered in the global transplantation preservation solutions market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the global transplantation preservation solutions market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2023 to 2030, due of the increase in the expenditure for research and development proficiencies, increasing government’s initiatives and improved health care infrastructure in various countries.

Asia-Pacific on the other hand is projected to exhibit the highest growth rate in the global transplantation preservation solutions market during the forecast period of 2023 to 2030 owing to the increasing government expenditure on healthcare sector and rising technological advancements and initiatives by the government.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

世界の移植保存ソリューション市場では、各国の医療設備支出の増加、世界の移植保存ソリューション市場向けのさまざまな種類の製品のインストールベース、ライフライン曲線を使用するテクノロジーの影響、医療規制シナリオの変更、およびそれらが世界の移植保存ソリューション市場に与える影響など、詳細な市場分析も提供されます。データは、2015年から2020年までの履歴期間で利用できます。

競争環境と世界の移植保存ソリューション市場シェア分析

世界の移植保存ソリューション市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性が含まれます。提供されている上記のデータ ポイントは、世界の移植保存ソリューション市場に関連する企業の焦点にのみ関連しています。

世界の移植保存ソリューション市場で活動している主要企業は次のとおりです。

• GSK plc. (米国)
• F. ホフマン・ラ・ロシュ社（スイス）
• ノバルティスAG（スイス）
• アストラゼネカ（米国）
• ファイザー社（米国）
• ブリストル・マイヤーズ スクイブ社（米国）
• サノフィ（米国）
• アムジェン社（米国）
• 第一三共株式会社（日本）
• AB Sciences（フランス）
• エーザイ株式会社（日本）
• ジェネンテック社（米国）
• メルク社（米国）

SKU-44890